Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
Autorino R, Gui B, Panza G, Boldrini L, Cusumano D, Russo L, Nardangeli A, Persiani S, Campitelli M, Ferrandina G, Macchia G, Valentini V, Gambacorta MA, Manfredi R. Autorino R, et al. Among authors: nardangeli a. Radiol Med. 2022 May;127(5):498-506. doi: 10.1007/s11547-022-01482-9. Epub 2022 Mar 24. Radiol Med. 2022. PMID: 35325372 Free PMC article. Review.
EROS study: evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis.
Autorino R, Tagliaferri L, Campitelli M, Smaniotto D, Nardangeli A, Mattiucci GC, Macchia G, Gui B, Miccò M, Mascilini F, Ferrandina G, Kovacs G, Valentini V, Gambacorta MA. Autorino R, et al. Among authors: nardangeli a. J Contemp Brachytherapy. 2018 Aug;10(4):315-320. doi: 10.5114/jcb.2018.77953. Epub 2018 Aug 31. J Contemp Brachytherapy. 2018. PMID: 30237815 Free PMC article.
Role of upper abdominal reirradiation for gastrointestinal malignancies: a systematic review of cumulative dose, toxicity, and outcomes on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Caravatta L, Fiorica F, Rosa C, Boldrini L, Alitto AR, Nardangeli A, Dionisi F, Bianco L, Munoz F, Lupattelli M, Mantello G, Genovesi D, Massaccesi M; Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Caravatta L, et al. Among authors: nardangeli a. Strahlenther Onkol. 2020 Jan;196(1):1-14. doi: 10.1007/s00066-019-01519-5. Epub 2019 Oct 4. Strahlenther Onkol. 2020. PMID: 31586232 English.
Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients.
Mattiucci GC, Boldrini L, Nardangeli A, D'Aviero A, Buwenge M, Cellini F, Deodato F, Dinapoli N, Frascino V, Macchia G, Morganti AG, Valentini V. Mattiucci GC, et al. Among authors: nardangeli a. J Cancer Res Clin Oncol. 2021 Mar;147(3):661-667. doi: 10.1007/s00432-020-03411-7. Epub 2020 Oct 1. J Cancer Res Clin Oncol. 2021. PMID: 33001271
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients.
Mattiucci GC, Boldrini L, Nardangeli A, D'Aviero A, Buwenge M, Cellini F, Deodato F, Dinapoli N, Frascino V, Macchia G, Morganti AG, Valentini V. Mattiucci GC, et al. Among authors: nardangeli a. J Cancer Res Clin Oncol. 2021 Mar;147(3):669. doi: 10.1007/s00432-020-03439-9. J Cancer Res Clin Oncol. 2021. PMID: 33165642 No abstract available.
Outcomes and toxicities of re-irradiation for prostate cancer: A systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Munoz F, Fiorica F, Caravatta L, Rosa C, Ferella L, Boldrini L, Fionda B, Alitto AR, Nardangeli A, Dionisi F, Arcangeli S, Di Marzo A, Pontoriero A, Donato V, Massaccesi M. Munoz F, et al. Among authors: nardangeli a. Cancer Treat Rev. 2021 Apr;95:102176. doi: 10.1016/j.ctrv.2021.102176. Epub 2021 Mar 8. Cancer Treat Rev. 2021. PMID: 33743409
Pretreatment MRI Radiomics Based Response Prediction Model in Locally Advanced Cervical Cancer.
Gui B, Autorino R, Miccò M, Nardangeli A, Pesce A, Lenkowicz J, Cusumano D, Russo L, Persiani S, Boldrini L, Dinapoli N, Macchia G, Sallustio G, Gambacorta MA, Ferrandina G, Manfredi R, Valentini V, Scambia G. Gui B, et al. Among authors: nardangeli a. Diagnostics (Basel). 2021 Mar 31;11(4):631. doi: 10.3390/diagnostics11040631. Diagnostics (Basel). 2021. PMID: 33807494 Free PMC article.
EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates.
Lancellotta V, Macchia G, Dinapoli N, Autorino R, Campitelli M, Nardangeli A, Salvati A, Fionda B, Casà C, Cornacchione P, Rovirosa A, Kovács G, Morganti AG, Ferrandina MG, Gambacorta MA, Tagliaferri L. Lancellotta V, et al. Among authors: nardangeli a. Radiol Med. 2022 Mar;127(3):341-348. doi: 10.1007/s11547-022-01455-y. Epub 2022 Jan 29. Radiol Med. 2022. PMID: 35092552 Free PMC article.
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups.
Macchia G, Nardangeli A, Laliscia C, Fodor A, Draghini L, Gentile PC, D'Agostino GR, Balcet V, Bonome P, Ferioli M, Autorino R, Vicenzi L, Raguso A, Borghesi S, Ippolito E, Di Cataldo V, Cilla S, Perrucci E, Campitelli M, Gambacorta MA, Deodato F, Scambia G, Ferrandina G. Macchia G, et al. Among authors: nardangeli a. Int J Gynecol Cancer. 2022 Jun 6;32(6):732-739. doi: 10.1136/ijgc-2021-003237. Int J Gynecol Cancer. 2022. PMID: 35193941
15 results